November 25, 2013
In a public letter dated November 22, the Food and Drug Administration has instructed personal genome startup 23andMe to immediately stop selling its testing service until the offering receives de novo 510(k) clearance. Regulatory Focus first spotted the letter.
"[M]onths after you submitted your 510(k)s and more than 5 years after you began marketing, you still had not...
March 19, 2013
UC Irvine researcher Gene Tsudik (Photo by Steve Zylius)
A team led by University of California-Irvine researchers has developed what's been called an Android-based smartphone paternity test. The app would allow two people, if they had access to their digitized genomes, to run a paternity test comparing their genomes, determine how closely related they are, and even scan their genome for...
January 7, 2013
Digital health incubator Rock Health has released it's 2012 year in review report, and it shows that venture capital investment in digital health is robust, if still tentative by some measures. Overall investment is up, but a large percentage of the numbers are accounted for by a few big deals and a few big investors.
Venture capitalists invested $1.4 billion in digital health in 2012, a 45...
October 28, 2009
At the TEDMED event here in San Diego this week, personal genomics company 23andMe co-founder Anne Wojcicki announced that the company now had more than 30,000 "active" genomes in its database and that it would soon launch a "Relative Finder" service for its users.
As part of the new service, users can explore connections to other users of the site to determine how related they are to each other...
June 10, 2009
At the Consumer Genetics Show in Boston today, genome sequencing company Illumina's President and CEO Jay Flatley announced that Illumina had partnered with four major direct-to-consumer genomics companies and demonstrated a very rough concept for a mobile application that leveraged a consumer's genomic profile.
Illumina inked partnerships with consumer-facing genome analysis services 23andme,...